HISTOLOGY AND CYTOLOGY MARKET ANALYSIS

Histology And Cytology Market, By Type of Examination (Histology and Cytology), By Application (Breast Cancer, Cervical Cancer, Bladder Cancer, Lung Cancer, Other), By Product (Instruments and Analysis Software System and Consumable and Reagents), By Test Type (Microscopy Tests , Cytogenic Tests, Polymerase Chain Reaction, Molecular Genetics Tests, Flow Cytomtery), By End User (Hospitals and Clinics, Academic and Research Institutes, Clinical Diagnostics Centre, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In May 2024, a leader in digital pathology services, HistoWiz, introduced GLP-compliant lab services, including routine histology and immunohistochemistry. This expansion builds on their expertise in pre-clinical research pathology, from tissue handling to slide digitization, and includes GLP pathology consultation.
In February 2024, Hologic, Inc. announced that its Genius Digital Diagnostics System, featuring the Genius Cervical AI algorithm, has received USFDA clearance. It is now the first and only FDA-cleared digital cytology system to integrate deep-learning AI with advanced volumetric imaging for detecting pre-cancerous lesions and cervical cancer cells.
In January 2024, BD (Becton, Dickinson and Company) and Techcyte have announced a strategic partnership to introduce an AI-based algorithm that helps cytologists and pathologists efficiently identify cervical cancer and precancer using whole-slide imaging.